{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:46:26Z","timestamp":1790084786092,"version":"4.0.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00702-011-0630-9","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T20:09:14Z","timestamp":1301688554000},"page":"1535-1546","source":"Crossref","is-referenced-by-count":49,"title":["A complex interaction between glycine\/NMDA receptors and serotonergic\/noradrenergic antidepressants in the forced swim test in mice"],"prefix":"10.1007","volume":"118","author":[{"given":"Ewa","family":"Poleszak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Kasperek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,2]]},"reference":[{"key":"630_CR1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","volume":"150","author":"CA Altamura","year":"1993","unstructured":"Altamura CA, Mauri MC, Ferrara A, Moro AR, D\u2019Andrea G, Zamberlan F (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150:1731\u20131733","journal-title":"Am J Psychiatry"},{"key":"630_CR2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00008877-200211000-00007","volume":"13","author":"PM Beardsley","year":"2002","unstructured":"Beardsley PM, Ratti E, Balster RL, Willetts J, Trist D (2002) The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects. Behav Pharmacol 13:583\u2013592","journal-title":"Behav Pharmacol"},{"key":"630_CR3","doi-asserted-by":"crossref","unstructured":"Bechtholt-Gompf AJ, Smith KL, John CS, Kang HH, Carlezon WA Jr, Cohen BM, \u00d6ng\u00fcr D (2011) CD-1 and Balb\/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy. Psychopharmacology (Berl) (in press) doi: 10.1007\/s00213-011-2169-8","DOI":"10.1007\/s00213-011-2169-8"},{"key":"630_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"630_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(99)00462-8","volume":"378","author":"F Bordi","year":"1999","unstructured":"Bordi F, Terron A, Reggiani A (1999) The neuroprotective glycine receptor antagonist GV150526 does not produce neuronal vacuolization or cognitive deficits in rats. Eur J Pharmacol 378:153\u2013160","journal-title":"Eur J Pharmacol"},{"key":"630_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","volume":"94","author":"F Borsini","year":"1988","unstructured":"Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94:147\u2013160","journal-title":"Psychopharmacology (Berl)"},{"key":"630_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2008.06.009","volume":"91","author":"D Boulay","year":"2008","unstructured":"Boulay D, Pichat P, Dargazanli G, Estenne-Bouhtou G, Terranova JP, Rogacki N, Stemmelin J, Coste A, Lanneau C, Desvignes C, Cohen C, Alonso R, Vige X, Biton B, Steinberg R, Sevrin M, Oury-Donat F, George P, Bergis O, Griebel G, Avenet P, Scatton B (2008) Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacol Biochem Behav 91:47\u201358","journal-title":"Pharmacol Biochem Behav"},{"key":"630_CR8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01382-6","volume":"50","author":"W Danysz","year":"1998","unstructured":"Danysz W, Parsons CG (1998) Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597\u2013664","journal-title":"Pharmacol Rev"},{"key":"630_CR9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0028-3908(91)90161-4","volume":"30","author":"MR Emmett","year":"1991","unstructured":"Emmett MR, Mick SJ, Cler JA, Rao TS, Iyengar S, Wood PL (1991) Actions of d-cycloserine at the N-methyl-d-aspartate-associated glycine receptor site in vivo. Neuropharmacology 30:1167\u20131171","journal-title":"Neuropharmacology"},{"key":"630_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","volume":"33","author":"AM Feyissa","year":"2009","unstructured":"Feyissa AM, Chandran A, Stockmeier CA, Karolewicz B (2009) Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 33:70\u201375","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"630_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0006-8993(96)01064-5","volume":"744","author":"JE Hawkinson","year":"1997","unstructured":"Hawkinson JE, Huber KR, Sahota PS, Han HH, Weber E, Whitehouse MJ (1997) The N-methyl-d-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain. Brain Res 744:227\u2013234","journal-title":"Brain Res"},{"key":"630_CR12","doi-asserted-by":"crossref","unstructured":"Hollister LE, Csernansky JG (1990) Clinical pharmacology of psychotherapeutic drugs. Churchill Livingstone, New York","DOI":"10.1097\/00004850-199010000-00009"},{"key":"630_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(89)90379-0","volume":"98","author":"WF Hood","year":"1989","unstructured":"Hood WF, Compton RP, Monahan JB (1989) d-cycloserine: a ligand for the N-methyl-d-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 98:91\u201395","journal-title":"Neurosci Lett"},{"key":"630_CR14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.npp.1300781","volume":"30","author":"B Karolewicz","year":"2005","unstructured":"Karolewicz B, Stockmeier CA, Ordway GA (2005) Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression. Neuropsychopharmacology 30:1557\u20131567","journal-title":"Neuropsychopharmacology"},{"key":"630_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S1461145708008985","volume":"12","author":"B Karolewicz","year":"2009","unstructured":"Karolewicz B, Szebeni K, Gilmore T, Maci\u0105g D, Stockmeier CA, Ordway GA (2009) Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int J Neuropsychopharmacol 12:143\u2013153","journal-title":"Int J Neuropsychopharmacol"},{"key":"630_CR16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0165-6147(93)90108-V","volume":"14","author":"JA Kemp","year":"1993","unstructured":"Kemp JA, Leeson PD (1993) The glycine site of the NMDA receptor\u2013five years on. Trends Pharmacol Sci 14:20\u201325","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl","key":"630_CR17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nn936","volume":"5","author":"JA Kemp","year":"2002","unstructured":"Kemp JA, McKernan RM (2002) NMDA receptor pathways as drug targets. Nat Neurosci 5(Suppl):1039\u20131042","journal-title":"Nat Neurosci"},{"key":"630_CR18","first-page":"438","volume":"73","author":"IV Kendig","year":"1956","unstructured":"Kendig IV, Charen S, Lepine LT (1956) Psychological side effects induced by cycloserine in the treatment of pulmonary tuberculosis. Am Rev Tuberc 73:438\u2013441","journal-title":"Am Rev Tuberc"},{"key":"630_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00345492","volume":"232","author":"JS Kim","year":"1982","unstructured":"Kim JS, Schmid-Burgk W, Claus D, Kornhuber HH (1982) Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr 232:299\u2013304","journal-title":"Arch Psychiatr Nervenkr"},{"key":"630_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)27497-3","volume":"154","author":"BK Koe","year":"1966","unstructured":"Koe BK, Weissman A (1966) p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 154:499\u2013516","journal-title":"J Pharmacol Exp Ther"},{"key":"630_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1211\/0022357001774156","volume":"52","author":"B Kroczka","year":"2000","unstructured":"Kroczka B, Zi\u0119ba A, Dudek D, Pilc A, Nowak G (2000) Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 52:403\u2013406","journal-title":"Pol J Pharmacol"},{"key":"630_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(01)00473-7","volume":"55","author":"B Kroczka","year":"2001","unstructured":"Kroczka B, Bra\u0144ski P, Pa\u0142ucha A, Pilc A, Nowak G (2001) Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 55:297\u2013300","journal-title":"Brain Res Bull"},{"key":"630_CR23","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","volume":"12","author":"AJ Law","year":"2001","unstructured":"Law AJ, Deakin JF (2001) Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 12:2971\u20132974","journal-title":"Neuroreport"},{"key":"630_CR24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(95)00155-P","volume":"52","author":"RT Layer","year":"1995","unstructured":"Layer RT, Popik P, Olds T, Skolnick P (1995) Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav 52:621\u2013627","journal-title":"Pharmacol Biochem Behav"},{"key":"630_CR25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0006-3223(99)00284-X","volume":"47","author":"J Levine","year":"2000","unstructured":"Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ, Pettegrew JW (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 47:586\u2013593","journal-title":"Biol Psychiatry"},{"key":"630_CR26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1378\/chest.32.2.172","volume":"32","author":"WC Lewis","year":"1957","unstructured":"Lewis WC, Calden G, Thurston JR, Gilson WE (1957) Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis. Dis Chest 32:172\u2013182","journal-title":"Dis Chest"},{"key":"630_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0160-5402(80)90052-2","volume":"4","author":"JJ Lipman","year":"1980","unstructured":"Lipman JJ, Spencer PS (1980) Rapid intracerebroventricular injection assisted by an automatic syringe. J Pharmacol Methods 4:327\u2013333","journal-title":"J Pharmacol Methods"},{"key":"630_CR28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(93)90250-L","volume":"242","author":"W L\u00f6scher","year":"1993","unstructured":"L\u00f6scher W, Annies R, H\u00f6nack D (1993) Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur J Pharmacol 242:263\u2013274","journal-title":"Eur J Pharmacol"},{"key":"630_CR29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349\u2013352","journal-title":"Biol Psychiatry"},{"key":"630_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0924-977X(92)90034-6","volume":"2","author":"J Maj","year":"1992","unstructured":"Maj J, Rog\u00f3\u017c Z, Skuza G, Sowi\u0144ska H (1992a) Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol 2:37\u201341","journal-title":"Eur Neuropsychopharmacol"},{"key":"630_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.2042-7158.1992.tb03617.x","volume":"44","author":"J Maj","year":"1992","unstructured":"Maj J, Rog\u00f3\u017c Z, Skuza G, Sowi\u0144ska H (1992b) The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol J Pharmacol Pharm 44:337\u2013346","journal-title":"Pol J Pharmacol Pharm"},{"key":"630_CR32","first-page":"115","volume":"46","author":"J Maj","year":"1994","unstructured":"Maj J, Rog\u00f3\u017c Z, Skuza G, Ko\u0142odziejczyk K (1994) Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5, 7-dichloro-kynurenic acid, glycine site antagonists. Pol J Pharmacol 46:115\u2013124","journal-title":"Pol J Pharmacol"},{"key":"630_CR33","first-page":"77","volume":"14","author":"P Mathis","year":"1988","unstructured":"Mathis P, Schmitt L, Benatia M, Granier F, Ghisolfi J, Moron P (1988) Plasma amino acid disturbances and depression. Encephale 14:77\u201382","journal-title":"Encephale"},{"key":"630_CR34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0091-3057(94)00300-8","volume":"50","author":"K Matsumoto","year":"1995","unstructured":"Matsumoto K, Ojima K, Watanabe H (1995) Noradrenergic denervation attenuates desipramine enhancement of aggressive behavior in isolated mice. Pharmacol Biochem Behav 50:481\u2013484","journal-title":"Pharmacol Biochem Behav"},{"key":"630_CR35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000026491","volume":"37","author":"MC Mauri","year":"1998","unstructured":"Mauri MC, Ferrara A, Boscati L, Bravin S, Zamberlan F, Alecci M, Invernizzi G (1998) Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37:124\u2013129","journal-title":"Neuropsychobiology"},{"key":"630_CR36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pnpbp.2005.11.021","volume":"30","author":"H Mitani","year":"2006","unstructured":"Mitani H, Shirayama Y, Yamada T, Kawahara R (2006) Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 30:531\u2013534","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"630_CR37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","volume":"72","author":"E Moryl","year":"1993","unstructured":"Moryl E, Danysz W, Quack G (1993) Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol Toxicol 72:394\u2013397","journal-title":"Pharmacol Toxicol"},{"key":"630_CR38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00057-W","volume":"675","author":"G Nowak","year":"1995","unstructured":"Nowak G, Ordway GA, Paul IA (1995) Alterations in the N-methyl-d-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675:157\u2013164","journal-title":"Brain Res"},{"key":"630_CR39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1211\/002235703322277186","volume":"55","author":"G Nowak","year":"2003","unstructured":"Nowak G, Siwek M, Dudek D, Zi\u0119ba A, Pilc A (2003) Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 55:1143\u20131147","journal-title":"Pol J Pharmacol"},{"key":"630_CR40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjp.0706845","volume":"149","author":"G Nowak","year":"2006","unstructured":"Nowak G, Partyka A, Pa\u0142ucha A, Szewczyk B, Wiero\u0144ska JM, Dyba\u0142a M, Metz M, Librowski T, Froestl W, Papp M, Pilc A (2006) Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. Br J Pharmacol 149:581\u2013590","journal-title":"Br J Pharmacol"},{"key":"630_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(96)00675-9","volume":"316","author":"M Papp","year":"1996","unstructured":"Papp M, Moryl E (1996) Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression. Eur J Pharmacol 316:145\u2013151","journal-title":"Eur J Pharmacol"},{"key":"630_CR42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","volume":"1003","author":"IA Paul","year":"2003","unstructured":"Paul IA, Skolnick P (2003) Glutamate and depression: clinical and preclinical studies. Ann NY Acad Sci 1003:250\u2013272","journal-title":"Ann NY Acad Sci"},{"key":"630_CR43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopsych.2008.09.029","volume":"65","author":"LE Phelps","year":"2009","unstructured":"Phelps LE, Brutsche N, Moral JR, Luckenbaugh DA, Manji HK, Zarate CA Jr (2009) Family history of alcohol dependence and initial antidepressant response to an N-methyl-d-aspartate antagonist. Biol Psychiatry 65:181\u2013184","journal-title":"Biol Psychiatry"},{"key":"630_CR44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00702-007-0714-8","volume":"114","author":"E Poleszak","year":"2007","unstructured":"Poleszak E (2007) Modulation of antidepressant-like activity of magnesium by serotonergic system. J Neural Transm 114:1129\u20131134","journal-title":"J Neural Transm"},{"key":"630_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2004.01.006","volume":"78","author":"E Poleszak","year":"2004","unstructured":"Poleszak E, Szewczyk B, K\u0119dzierska E, Wla\u017a P, Pilc A, Nowak G (2004) Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav 78:7\u201312","journal-title":"Pharmacol Biochem Behav"},{"key":"630_CR46","first-page":"654","volume":"57","author":"E Poleszak","year":"2005","unstructured":"Poleszak E, Wla\u017a P, K\u0119dzierska E, Radziwo\u0144-Zaleska M, Pilc A, Fidecka S, Nowak G (2005a) Effects of acute and chronic treatment with magnesium in the forced swim test in rats. Pharmacol Rep 57:654\u2013658","journal-title":"Pharmacol Rep"},{"key":"630_CR47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pbb.2005.03.017","volume":"81","author":"E Poleszak","year":"2005","unstructured":"Poleszak E, Wla\u017a P, Szewczyk B, K\u0119dzierska E, Wyska E, Librowski T, Szymura-Oleksiak J, Fidecka S, Pilc A, Nowak G (2005b) Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: behavioral and pharmacokinetic studies in mice. Pharmacol Biochem Behav 81:524\u2013529","journal-title":"Pharmacol Biochem Behav"},{"key":"630_CR48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pbb.2007.07.018","volume":"88","author":"E Poleszak","year":"2007","unstructured":"Poleszak E, Wla\u017a P, K\u0119dzierska E, Nieoczym D, Wr\u00f3bel A, Fidecka S, Pilc A, Nowak G (2007a) NMDA\/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav 88:158\u2013164","journal-title":"Pharmacol Biochem Behav"},{"key":"630_CR49","first-page":"595","volume":"59","author":"E Poleszak","year":"2007","unstructured":"Poleszak E, Wla\u017a P, Wr\u00f3bel A, Dyba\u0142a M, Sowa M, Fidecka S, Pilc A, Nowak G (2007b) Activation of the NMDA\/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacol Rep 59:595\u2013600","journal-title":"Pharmacol Rep"},{"key":"630_CR50","first-page":"996","volume":"60","author":"E Poleszak","year":"2008","unstructured":"Poleszak E, Szewczyk B, Wla\u017a A, Fidecka S, Wla\u017a P, Pilc A, Nowak G (2008) d-serine, a selective glycine\/N-methyl-d-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacol Rep 60:996\u20131000","journal-title":"Pharmacol Rep"},{"key":"630_CR51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00213-008-1158-z","volume":"198","author":"P Popik","year":"2008","unstructured":"Popik P, Kos T, Sowa-Ku\u0107ma M, Nowak G (2008) Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology (Berl) 198:421\u2013430","journal-title":"Psychopharmacology (Berl)"},{"key":"630_CR52","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"630_CR53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","volume":"28","author":"SH Preskorn","year":"2008","unstructured":"Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW (2008) An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101, 606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol 28:631\u2013637","journal-title":"J Clin Psychopharmacol"},{"key":"630_CR54","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","volume":"66","author":"RB Price","year":"2009","unstructured":"Price RB, Nock MK, Charney DS, Mathew SJ (2009) Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66:522\u2013526","journal-title":"Biol Psychiatry"},{"key":"630_CR55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0028-3908(96)00157-8","volume":"36","author":"E Przegali\u0144ski","year":"1997","unstructured":"Przegali\u0144ski E, Tatarczy\u0144ska E, Dere\u0144-Weso\u0142ek A, Chojnacka-W\u00f3jcik E (1997) Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist. Neuropharmacology 36:31\u201337","journal-title":"Neuropharmacology"},{"key":"630_CR56","first-page":"349","volume":"50","author":"E Przegali\u0144ski","year":"1998","unstructured":"Przegali\u0144ski E, Tatarczy\u0144ska E, Chojnacka-W\u00f3jcik E (1998) Anxiolytic- and antidepressant-like effects of an antagonist at glycine B receptors. Pol J Pharmacol 50:349\u2013354","journal-title":"Pol J Pharmacol"},{"issue":"Suppl B","key":"630_CR57","first-page":"9","volume":"51","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E (1990) Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 51(Suppl B):9\u201312","journal-title":"J Clin Psychiatry"},{"key":"630_CR58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2006.07.002","volume":"113","author":"S Rosenzweig-Lipson","year":"2007","unstructured":"Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, Rahman Z, Ring RH, Schechter LE (2007) Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther 113:134\u2013153","journal-title":"Pharmacol Ther"},{"key":"630_CR59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","volume":"61","author":"G Sanacora","year":"2004","unstructured":"Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF (2004) Subtype-specific alterations of \u03b3-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705\u2013713","journal-title":"Arch Gen Psychiatry"},{"key":"630_CR60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2009.02.014","volume":"118","author":"M Siwek","year":"2009","unstructured":"Siwek M, Dudek D, Paul IA, Sowa-Ku\u0107ma M, Zi\u0119ba A, Popik P, Pilc A, Nowak G (2009) Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 118:187\u2013195","journal-title":"J Affect Disord"},{"key":"630_CR61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","volume":"375","author":"P Skolnick","year":"1999","unstructured":"Skolnick P (1999) Antidepressants for the new millennium. Eur J Pharmacol 375:31\u201340","journal-title":"Eur J Pharmacol"},{"key":"630_CR62","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0024-3205(89)90274-9","volume":"45","author":"P Skolnick","year":"1989","unstructured":"Skolnick P, Marviz\u00f3n JC, Jackson BW, Monn JA, Rice KC, Lewin AH (1989) Blockade of N-methyl-d-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci 45:1647\u20131655","journal-title":"Life Sci"},{"key":"630_CR63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF02245261","volume":"107","author":"P Skolnick","year":"1992","unstructured":"Skolnick P, Miller R, Young A, Boje K, Trullas R (1992) Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-d-aspartate receptor complex. Psychopharmacology (Berl) 107:489\u2013496","journal-title":"Psychopharmacology (Berl)"},{"key":"630_CR64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","volume":"29","author":"P Skolnick","year":"1996","unstructured":"Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R (1996) Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 29:23\u201326","journal-title":"Pharmacopsychiatry"},{"key":"630_CR65","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","volume":"30","author":"P Skolnick","year":"2009","unstructured":"Skolnick P, Popik P, Trullas R (2009) Glutamate-based antidepressants: 20\u00a0years on. Trends Pharmacol Sci 30:563\u2013569","journal-title":"Trends Pharmacol Sci"},{"key":"630_CR66","first-page":"588","volume":"60","author":"B Szewczyk","year":"2008","unstructured":"Szewczyk B, Poleszak E, Sowa-Ku\u0107ma M, Siwek M, Dudek D, Ryszewska-Pokra\u015bniewicz B, Radziwo\u0144-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G (2008) Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 60:588\u2013589","journal-title":"Pharmacol Rep"},{"key":"630_CR67","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pnpbp.2008.12.011","volume":"33","author":"B Szewczyk","year":"2009","unstructured":"Szewczyk B, Poleszak E, Wla\u017a P, Wr\u00f3bel A, Blicharska E, Cichy A, Dyba\u0142a M, Siwek A, Pomierny-Chamio\u0142o L, Piotrowska A, Bra\u0144ski P, Pilc A, Nowak G (2009) The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 33:323\u2013329","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"630_CR68","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00726-009-0412-y","volume":"39","author":"B Szewczyk","year":"2010","unstructured":"Szewczyk B, Poleszak E, Sowa-Ku\u0107ma M, Wr\u00f3bel A, S\u0142otwi\u0144ski S, Listos J, Wla\u017a P, Cichy A, Siwek A, Dyba\u0142a M, Go\u0142embiowska K, Pilc A, Nowak G (2010) The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids 39:205\u2013217","journal-title":"Amino Acids"},{"key":"630_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","volume":"185","author":"R Trullas","year":"1990","unstructured":"Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185:1\u201310","journal-title":"Eur J Pharmacol"},{"key":"630_CR70","first-page":"209","volume":"56","author":"A Vamvakides","year":"1998","unstructured":"Vamvakides A (1998) d-cycloserine is active in the adult mouse and inactive in the aged mouse, in the forced swim test. Ann Pharm Fr 56:209\u2013212","journal-title":"Ann Pharm Fr"},{"key":"630_CR71","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4088\/JCP.v60n0610","volume":"60","author":"M Versiani","year":"1999","unstructured":"Versiani M, Mehilane L, Gaszner P, Arnaud-Castiglioni R (1999) Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder. J Clin Psychiatry 60:400\u2013406","journal-title":"J Clin Psychiatry"},{"key":"630_CR72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0006-8993(90)90745-W","volume":"510","author":"GB Watson","year":"1990","unstructured":"Watson GB, Bolanowski MA, Baganoff MP, Deppeler CL, Lanthorn TH (1990) d-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res 510:158\u2013160","journal-title":"Brain Res"},{"issue":"Suppl 17","key":"630_CR73","first-page":"4","volume":"60","author":"HG Westenberg","year":"1999","unstructured":"Westenberg HG (1999) Pharmacology of antidepressants: selectivity or multiplicity? J Clin Psychiatry 60(Suppl 17):4\u20138","journal-title":"J Clin Psychiatry"},{"key":"630_CR74","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0165-6147(90)90150-7","volume":"11","author":"J Willetts","year":"1990","unstructured":"Willetts J, Balster RL, Leander JD (1990) The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423\u2013428","journal-title":"Trends Pharmacol Sci"},{"key":"630_CR75","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1471-4159.1989.tb11803.x","volume":"53","author":"PL Wood","year":"1989","unstructured":"Wood PL, Emmett MR, Rao TS, Mick S, Cler J, Iyengar S (1989) In vivo modulation of the N-methyl-d-aspartate receptor complex by d-serine: potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP. J Neurochem 53:979\u2013981","journal-title":"J Neurochem"},{"key":"630_CR76","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1046\/j.1471-4159.1996.67041485.x","volume":"67","author":"PL Wood","year":"1996","unstructured":"Wood PL, Hawkinson JE, Goodnough DB (1996) Formation of d-serine from l-phosphoserine in brain synaptosomes. J Neurochem 67:1485\u20131490","journal-title":"J Neurochem"},{"key":"630_CR77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(97)00568-4","volume":"765","author":"QS Yan","year":"1997","unstructured":"Yan QS, Reith ME, Jobe PC, Dailey JW (1997) Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res 765:149\u2013158","journal-title":"Brain Res"},{"key":"630_CR78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1176\/appi.ajp.161.1.171","volume":"161","author":"CA Zarate Jr","year":"2004","unstructured":"Zarate CA Jr, Payne JL, Quiroz J, Sporn J, Denicoff KK, Luckenbaugh D, Charney DS, Manji HK (2004) An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 161:171\u2013174","journal-title":"Am J Psychiatry"},{"key":"630_CR79","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","volume":"57","author":"CA Zarate Jr","year":"2005","unstructured":"Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK (2005) An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 57:430\u2013432","journal-title":"Biol Psychiatry"},{"key":"630_CR80","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006a) A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"630_CR81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","volume":"163","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Quiroz JA, De Jesus G, Denicoff KK, Luckenbaugh DA, Manji HK, Charney DS (2006b) A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry 163:153\u2013155","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00702-011-0630-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:53:30Z","timestamp":1741118010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0630-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,2]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0630-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,2]]}}}